FDA Warning Letter — BP
The FDA took a Warning Letter action against BP on Feb 23, 2017 (Silver Spring, MD). The action was issued by CTP and concerns tobacco products.
Action Details
- Facility
- BP
- Date
- Feb 23, 2017
- Fiscal Year
- 2017
- Product Type
- Tobacco
- Center
- CTP
- Location
- Silver Spring, MD (United States)